“Welcome to the Advocacy for Neuroacanthocytosis Patients (NA Advocacy) Neuroacanthocytosis (NA) is an ultra rare neurological syndrome that causes the diseases chorea-acanthocytosis (VPS13 Disease) and McLeod Syndrome (XK Disease). The Advocacy for Neuroacanthocytosis Patients was established in…”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Balance sheet as at 31 August 2025 · total exemption full accounts
| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Current Assets | £236,686 | £199,534 | £223,592 | £157,876 | £212,852 | £130,944 |
| Debtors | £266 | £0 | £8,510 | £41 | £41 | |
| Cash | £41,133 | £38,557 | £114,005 | £30,895 | £112,811 | £130,903 |
| Creditors (< 1 year) | £2,188 | £1,269 | £661 | £641 | £629 | |
| Net Current Assets | £234,214 | £197,346 | £222,323 | £157,215 | £212,211 | £130,315 |
| Net Assets | £234,214 | £197,346 | £222,323 | £157,215 | £212,211 | £130,315 |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 1 June 2026 | Total exemption full accounts | 31 August 2025 | ||
| 23 February 2026 | Termination of appointment of a director | |||
| 15 September 2025 | Confirmation statement with no updates | 31 August 2025 | ||
| 7 July 2025 | Total exemption full accounts | 31 August 2024 | ||
| 3 September 2024 | Appointment of a director |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →